Glenmark Pharmaceuticals
Mumbai, Maharashtra, India · Biopharma, Biotechnology, Manufacturing
Glenmark Pharmaceuticals is a pharmaceutical company headquartered in Mumbai, India. The company focuses on the discovery, development, manufacturing, and marketing of a wide range of pharmaceutical products, including branded and generic formulations, biologics, and active pharmaceutical ingredients (APIs).
Key facts
- Headquarters
- Mumbai, Maharashtra, India
- Employees
- 15,000
- Industries
- Biopharma, Biotechnology, Manufacturing
- Website
- glenmarkpharma.com
- Company page
Recent activity at Glenmark Pharmaceuticals
- : Glenmark Pharmaceuticals Inc., USA launches Micafungin for Injection USP in 50 mg and 100 mg vials to expand its institutional product offerings.
- : Glenmark Pharmaceuticals Appoints Anurag Mantri as Chief Financial Officer
- : Glenmark Pharmaceuticals Inc., USA launches Phytonadione Injectable Emulsion USP, aiming to strengthen its institutional product portfolio.
- : Zoya Pandey Appointed as General Manager at Glenmark Pharmaceuticals
Leadership
- Parekh Krunal, Filed Sales Officer
- Viren Doshi, Global Talent Acquisition Leader
- Harsh Gupta, Senior Research Scientist (Team Leader)
- Umesh Gupta, Vice President Operations (Cluster Head)
- Sravan Tripathi, Assistant Manager
- Mariano Rozada, Vice President for Upper Latam & Managing Director Mexico
- Harsh Chheda, Project Manager
- Ajit Jagadale, Senior Research Scientist
- Vandana Saraf, Assistant Manager
- Sankhyadeep Dutta, Marketing Manager
- Joe Paul Philip, Vice President and Global Head, Manufacturing Science and Technology
- Bhagyeshkumar Patel, Medical Sales Representative
Verified email and direct lines for Glenmark Pharmaceuticals’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Glenmark Pharmaceuticals in the news
- Glenmark Specialty SA Receives U.S. FDA Approval for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation, with 180-Day Competitive Generic Therapy Exclusivity - PR Newswire (Mar 04, 2026)
- India's Glenmark Pharma posts higher quarterly profit on strong demand - Yahoo Finance (Jul 31, 2026)
- The FDA Hasn’t Inspected This Drug Factory After 7 Recalls for the Same Flaw, 1 Potentially Deadly - ProPublica (Dec 12, 2024)
- Glenmark Pharmaceuticals launches Fingolimod Capsules, 0.5 mg in the US - BioSpace (Oct 31, 2022)
- Generic Immunosuppressive Drug Receives FDA Approval - Pharmacy Times (Nov 11, 2020)
- Glenmark Pharmaceuticals and South Piedmont Community College Launch Aseptic Training Facility in Monroe, N.C. - PR Newswire (Sep 10, 2026)
- GLENMARK Share Price Today - Glenmark Pharmaceuticals Stock Analysis - Equitypandit (Jul 14, 2023)
- Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials - PR Newswire (Jul 28, 2026)
Companies similar to Glenmark Pharmaceuticals
- Jazz Pharmaceuticals plc · Biopharma, Biotechnology, Manufacturing, Pharmaceutical
- Celltrion · Biopharma, Biotechnology, Manufacturing, Pharmaceutical
- Dr. Reddy's Laboratories · Biotechnology, Manufacturing, Pharmaceutical, pharmaceuticals
- Cipla · Biotechnology, Manufacturing, Pharmaceutical, pharmaceuticals
- FAMAR Group · Biotechnology, Manufacturing, Pharmaceutical, pharmaceuticals
About Glenmark Pharmaceuticals: questions and answers
What does Glenmark Pharmaceuticals do?
Glenmark Pharmaceuticals is a pharmaceutical company headquartered in Mumbai, India. The company focuses on the discovery, development, manufacturing, and marketing of a wide range of pharmaceutical products, including branded and generic formulations, biologics, and active pharmaceutical ingredients (APIs).
Where is Glenmark Pharmaceuticals headquartered?
Glenmark Pharmaceuticals is headquartered in Mumbai, Maharashtra, India.
How many employees does Glenmark Pharmaceuticals have?
Glenmark Pharmaceuticals has about 15,000 employees.
Who leads Glenmark Pharmaceuticals?
Umesh Gupta is a Vice President Operations (Cluster Head) at Glenmark Pharmaceuticals.
What is the latest news on Glenmark Pharmaceuticals?
On Aug 19, 2025, Glenmark Pharmaceuticals Inc., USA launches Micafungin for Injection USP in 50 mg and 100 mg vials to expand its institutional product offerings.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy